ÂÜÀòÂÒÂ×

JD Schaub currently serves as Executive Vice President and Chief Operating Officer at RVL Pharmaceuticals, Inc., a position held since December 2013. Prior to this role, JD Schaub was Executive Vice President of Commercial Operations and Chief Operating Officer at Osmotica/Vertical/Trigen, where tenure spanned from December 2013 to December 2021. JD Schaub’s earlier experience includes consulting for the healthcare industry at Avista Capital, serving as Vice President of M&A and Portfolio Strategy at Fougera Pharmaceuticals Inc., and holding various positions at Pfizer and King Pharmaceuticals, including Director of Business Development and Senior Manager of Business Development & Licensing. JD Schaub earned an MBA in Pharmaceutical Marketing and Management from Rutgers Business School and a Bachelor of Arts in Economics from Middlebury College.